I'm not too sure about that. Maybe it is synapses that disappear or change, or hair cells are just bent but still alive, or there is damage to the hearing nerve or its coating.The permanent hearing loss (and hearing decline) is related to the hair cell death, though. I wonder if FX-322 in conjunction with a salt restricted diet and diuretics would help once the drug can reach the lower registers.
I tried to get in the trial but was rejected unfortunately. Not at the NY location, though.Did you try this therapy?
That's exactly what I would think but somehow you can lose close to 100% of IHCs in a spot and still hear pure tones. Don't ask me how. It makes zero sense to me but that appears to be the case.I'm not very informed on the subject but it seems that without the IHC's no signal would go through, even when OHC's are still present.
Meniere's does not affect the auditory nerve. I have never heard it affects the synapses but I guess it's possible.I'm not too sure about that. Maybe it is synapses that disappear or change, or hair cells are just bent but still alive, or there is damage to the hearing nerve or its coating.
In the cochlea. You have 3 rows of outer hair cells (OHCs) and 1 row of inner hair cells (IHCs).Hello everyone, I'm curious where are the little hairs located in our ear?
Wouldn't that be the off-frequency listening they refer to in the study I posted?That's exactly what I would think but somehow you can lose close to 100% of IHCs in a spot and still hear pure tones. Don't ask me how. It makes zero sense to me but that appears to be the case.
Thank you.In the cochlea. You have 3 rows of outer hair cells (OHCs) and 1 row of inner hair cells (IHCs).
When one loses ability to understand speech in noise, it is still easy to enjoy music. That's a big difference!That's exactly what I would think but somehow you can lose close to 100% of IHCs in a spot and still hear pure tones. Don't ask me how. It makes zero sense to me but that appears to be the case.
I did not know that this was a common outcome. I thought that Meniere's Disease was essentially a permanent establishment of the unusual pressure condition. The reason I believed that is that a few treatments that are proposed for Meniere's Disease would not make sense if the hair cells were already dead, for example:This is the "fluctuating hearing loss" but over time, I believe there is permanent hearing loss from ischemia killing off hair cells (versus the effects of hydrops where hearing and tinnitus can get much better after an "attack").
I did not know that this was a common outcome. I thought that Meniere's Disease was essentially a permanent establishment of the unusual pressure condition. The reason I believed that is that a few treatments that are proposed for Meniere's Disease would not make sense if the hair cells were already dead, for example:
Perhaps these are only offered when the patients haven't progressed to a severe stage?
- gentamycin injections: they are meant to actually kill the hair cells, so they cannot sending "bogus signals" anymore, which wouldn't be needed if they were already dead
- endolymphatic sac decompression surgery: meant to actuate on the pressure and restore a normal state on hair cells, which would be unneeded if the hair cells were already dead
Can you try to get in again, adjusting certain responses (such as your availability, for example, if you're willing to relocate to their area for a month)?I tried to get in the trial but was rejected unfortunately. Not at the NY location, though.
I'm pretty sure there were 2 New York locations. I checked the locations again and Florida seem to have 3 locations now. Before it was only 2.There was only ever one NY location (Amherst).
I distinctly remember 3 Florida locations:I'm pretty sure there were 2 New York locations. I checked the locations again and Florida seem to have 3 locations now. Before it was only 2.
They still have estimated participants at 96.
I was ultimately rejected for my audiogram so it wouldn't do any good.Can you try to get in again, adjusting certain responses (such as your availability, for example, if you're willing to relocate to their area for a month)?
I've been checking for updates everyday so I can let you guys know and post it on here.Nothing constructive to add, just want to say a big thank you to all those on here who spend time finding papers, updates, and tirelessly and patiently explaining concepts so that we can better understand this condition and the research that is being done to help us. It's really uplifting on bad days.
I thought it killed indiscriminately? (we'd want it to target vestibular regions, but we don't get to choose where the meds diffuse, so we end up with "collateral damage" in the cochlea because it is also toxic to the hair cells in the cochlea)Gentamycin is used in Meniere's to kill the vestibular hair cells, not the OHCs/IHCs. It is primarily vestibulotoxic and that's why it is used.
Does it not improve hearing outcomes?Decompression surgery also is not used to improve hearing outcomes, just reduce vestibular symptoms.
They are not indiscriminate at all. Below is a link to a slide I found online but there is a ton of literature about this. There is a reason gentamycin in particular is used.I thought it killed indiscriminately? (we'd want it to target vestibular regions, but we don't get to choose where the meds diffuse, so we end up with "collateral damage" in the cochlea because it is also toxic to the hair cells in the cochlea)
Does it not improve hearing outcomes?
I agree, but isn't it the case that, even though gentamicin targets vestibular cells, it is also toxic to cochlea cells? I thought that was the reason explaining the hearing loss side effect from gentamicin treatment?They are not indiscriminate at all. Below is a link to a slide I found online but there is a ton of literature about this. There is a reason gentamycin in particular is used.
What I have always understood is it is not well taken up by cochlear cells but with very high doses I'm sure it's toxic to everything it touches.I agree, but isn't it the case that, even though gentamicin targets vestibular cells, it is also toxic to cochlea cells? I thought that was the reason explaining the hearing loss side effect from gentamicin treatment?
This page has interesting explanations about loss of hearing due to the treatment, with various dosage:
https://www.dizziness-and-balance.com/treatment/ttg.html
The full dosing won't reach that range per their presentations. I think it's quite plausible they will reformulated in some way to reach the lower frequencies but that may happen a year later. They had job postings recently to hire someone with formulation experience including, intratympanic drug formulations. FX-322 is the only drug in the platform that is for intratympanic use. I think it's a really good sign they hope to eventually get all frequencies.I'm trying to be optimistic about this treatment but isn't it true that it won't impact frequencies below 3000 Hz? What about those of us who have tinnitus below this frequency?
In a way you already can. Go buy some stock.Come on Frequency I'm ready to give you some cash.
And isn't Audion's Regain ironically supposed to have better penetrance at the apex? So worst case scenario perhaps we could combine the two treatments? Although I would rather have Frequency be able to cover everything in the interest of preserving support cells.The full dosing won't reach that range per their presentations. I think it's quite plausible they will reformulated in some way to reach the lower frequencies but that may happen a year later. They had job postings recently to hire someone with formulation experience including, intratympanic drug formulations. FX-322 is the only drug in the platform that is for intratympanic use. I think it's a really good sign they hope to eventually get all frequencies.
They haven't said nearly as much about their product as Frequency has.And isn't Audion's Regain ironically supposed to have better penetrance at the apex? So worst case scenario perhaps we could combine the two treatments? Although I would rather have Frequency be able to cover everything in the interest of preserving support cells.
Audion/Regain will release their results in May so they may mention more about the drug but Frequency Therapeutics have been more open about FX-322.And isn't Audion's Regain ironically supposed to have better penetrance at the apex? So worst case scenario perhaps we could combine the two treatments? Although I would rather have Frequency be able to cover everything in the interest of preserving support cells.
We can't buy stock from Audion, can we?Audion/Regain will release their results in May so they may mention more about the drug but Frequency Therapeutics have been more open about FX-322.